Trademark: 79339793
Word
APTAMER GROUP
Status Date
Tuesday, November 28, 2023
Registration Number
7226871
Registration Date
Tuesday, November 28, 2023
Filing Date
Tuesday, June 29, 2021
Published for Opposition
Tuesday, September 12, 2023
5 Reagents for medical use; chemical reagents for medical use; medical, veterinary, clinical, diagnostic and pharmaceutical reagents, agents, chemicals, materials, substances and preparations, namely, clinical medical reagents, reagents for medical use, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic agents, preparations and substances for medical purposes; optimised aptamer molecules for medical and veterinary use, namely, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic media for bacteriological cultures; medical and veterinary diagnostic reagents and assays for testing of body fluids; medical and veterinary diagnostic test strips for the analysis of blood, urine, saliva, human tissue and animal tissue; diagnostic biomarker reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic or treatment purposes, namely, diagnostic reagents and contrast media for medical use; nucleic acids in the form of diagnostic reagents for medical, veterinary, diagnostic and pharmaceutical purposes, namely nucleic acids and chemical reagents for medical and veterinary purposes; nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes; diagnostic testing kits comprised of medical diagnostic reagents, assays, monoclonal antibodies, buffers and reagents for testing of bodily fluids, human tissue and animal tissue for use in disease detection; diagnostic reagents for medical and veterinary use for sale in kit form; diagnostic kits comprising specimen receptors and reagents for medical, veterinary and diagnostic testing in the nature of diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids, human tissue and animal tissue for use in disease detection; medical and veterinary diagnostic reagents and assays for testing of fluids
44 Medical, veterinary and diagnostic services, namely, medical testing for diagnostic or treatment purposes, virus testing for medical diagnostic or treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing services namely, genetic testing for medical, diagnostic and treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing for diagnostic or treatment purposes; medical and veterinary analysis services for diagnostic and treatment purposes, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; medical and veterinary testing services relating to diagnosis and treatment; medical and veterinary analysis services, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; information and advisory services in respect of the aforementioned services
10 Medical and veterinary apparatus, instruments, equipment, tools and devices, namely, medical and veterinary apparatus and instruments for use in bodily fluid analysis and testing; medical and veterinary diagnostic apparatus, instruments, equipment, tools and devices, namely, diagnostic apparatus and instruments for use in bodily fluid analysis and testing; medical and veterinary diagnostic apparatus, instruments, equipment, tools and devices for testing for viruses, namely, medical diagnostic apparatus for testing for viruses; apparatus, instruments, equipment, tools and devices for carrying out diagnostic tests for medical and veterinary purposes, namely, medical diagnostic apparatus for testing DNA and RNA samples, medical diagnostic apparatus for testing for viruses, medical diagnostic apparatus for testing of bodily fluids; diagnostic testing kits consisting primarily of probes, buffers and reagents for use in microbial testing; structural parts and fittings for all the aforesaid goods
42 Research and development services in the field of medical diagnostics and medical testing; product design and development of diagnostic apparatus, instruments, equipment, tools and devices; product research, design and development in the field of diagnostic preparations; product research, design and development of reagents; product research, design and development of aptamer reagents; product research, design and development of aptamer reagents for integration into diagnostic platforms; product research, design and development of reagents for therapeutic applications; product research, design and development of aptamer reagents for therapeutic applications; custom product development of reagents; custom product development of aptamer reagents; medical research, namely, optimsation of aptamer molecules; product research, design and development of nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes; product research, design and development of nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes; laboratory testing services namely, testing of pharmaceuticals and medical laboratory testing services; medical and scientific laboratory services for analytical testing; design and development of testing and analysis methods namely, research and development of advanced learning technologies and teaching methods; medical and scientific laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; medical and veterinary research services; medical and veterinary laboratory services; scientific research and investigations for medical and veterinary purposes; medical and scientific laboratory services, namely, analysis of human and animal tissues and samples for medical and veterinary research; biological research, clinical research, medical research and veterinary research in the field of medical diagnostics and medical testing; provision of information and data relating to medical and veterinary research and development; information and advisory services in respect of the aforementioned services
The mark consists of a design of a single blue line polygon open at the top and bottom with a design of a blue DNA helix inside and connected to a polygon at the top and bottom. With the wording "APTAMER GROUP" in a stylized stacked black font underneath. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
The color(s) blue and black is/are claimed as a feature of the mark.
"GROUP"
Mar 26, 2024
Final Decision Transaction Processed By Ib
Feb 29, 2024
Final Disposition Notice Sent To Ib
Feb 29, 2024
Final Disposition Processed
Feb 28, 2024
Final Disposition Notice Created, To Be Sent To Ib
Nov 28, 2023
Notice Of Registration Confirmation Emailed
Nov 28, 2023
Registered-Principal Register
Oct 31, 2023
Notification Of Possible Opposition - Processed By Ib
Oct 11, 2023
Notification Of Possible Opposition Sent To Ib
Oct 11, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Sep 12, 2023
Notification Processed By Ib
Sep 12, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 12, 2023
Published For Opposition
Aug 23, 2023
Notification Of Possible Opposition Sent To Ib
Aug 23, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 23, 2023
Notification Of Notice Of Publication E-Mailed
Aug 9, 2023
Approved For Pub - Principal Register
Aug 5, 2023
Suspension Checked - To Attorney For Action
Jul 31, 2023
Teas/Email Correspondence Entered
Jul 31, 2023
Correspondence Received In Law Office
Jul 31, 2023
Teas Response To Suspension Inquiry Received
Jan 20, 2023
Notification Of Letter Of Suspension E-Mailed
Jan 20, 2023
Letter Of Suspension E-Mailed
Jan 20, 2023
Suspension Letter Written
Dec 16, 2022
Teas/Email Correspondence Entered
Dec 15, 2022
Correspondence Received In Law Office
Dec 15, 2022
Teas Response To Office Action Received
Jul 6, 2022
Refusal Processed By Ib
Jun 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 14, 2022
Refusal Processed By Mpu
May 14, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 13, 2022
Non-Final Action Written
May 10, 2022
Application Filing Receipt Mailed
May 6, 2022
Assigned To Examiner
May 6, 2022
New Application Office Supplied Data Entered
May 5, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
